Derma Sciences Regions Map

Select your location from over 190 countries where Derma Sciences operates.

AMNIOTIC Tissue Products

AMNIOEXCEL® Product Ordering Information

scroll
scroll
Order Code Size Product Name/Description HCPCS
25012 12 mm disk AMNIOEXCEL® Allograft Membrane – 1 cm2 Q4137 amnioexcel
25013 15 mm disk AMNIOEXCEL® Allograft Membrane – 2 cm2 Q4137
25018 18 mm disk AMNIOEXCEL® Allograft Membrane – 3 cm2 Q4137
25024 24 mm disk AMNIOEXCEL® Allograft Membrane – 5 cm2 Q4137
25015 1.5 cm x 1.5 cm AMNIOEXCEL® Allograft Membrane – 2 cm2 Q4137
25023 2.0 cm x 3.0 cm AMNIOEXCEL® Allograft Membrane – 6 cm2 Q4137
25035 3.5 cm x 3.5 cm AMNIOEXCEL® Allograft Membrane – 12 cm2 Q4137
25044 4.0 cm x 4.0 cm AMNIOEXCEL® Allograft Membrane – 16 cm2 Q4137
25048 4.0 cm x 8.0 cm AMNIOEXCEL® Allograft Membrane – 32 cm2 Q4137
25055 5.0 cm x 5.0 cm AMNIOEXCEL® Allograft Membrane – 25 cm2 Q4137
25110 10.0 cm x 10.0 cm AMNIOEXCEL® Allograft Membrane – 100 cm2 Q4137

AMNIOEXCEL® is regulated by the FDA under 21 CFR Part 1271 and Section 361 of the Public Health Service Act.


AMNIOMATRIX® Product Ordering Information

scroll
scroll
Order Code Total Units Product Name/Description HCPCS
25510 1 AMNIOMATRIX® Allograft Suspension – 0.25 ml Q4139 amniomatrix
25520 1 AMNIOMATRIX® Allograft Suspension – 0.50 ml Q4139
25530 1 AMNIOMATRIX® Allograft Suspension – 1.0 ml Q4139
25540 2 AMNIOMATRIX® Allograft Suspension – 2.0 ml Q4139
25550 3 AMNIOMATRIX® Allograft Suspension – 3.0 ml Q4139

1. Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, et al. Comprehensive foot examination and risk assessment: A report of the task force of the foot care interest group of the ADA, with endorsement by the AACE. Diabetes Care 2008; 8: 1679-1685. 2. Holzer SE, Camerota A, Marens L, et al. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther 1998; 20:169-181. 3. Davis JW. Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital. Johns Hopkins Med J. 1910; 15: 307-396. 4. Zelen CM, Serena TE et al. A prospective randomized comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers. Int Wound J ISSN 1742-4801. 2013; June: 1-6. 5. Ueta M, Kweon M-N, Sano Y, Sotozono C, et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immun 2002; 129:464-470. 6. Hao Y, Ma DH, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and anti-inflammatory proteins in human amniotic membrane. Cornea 2000; 19: 348-352. 7. Kjaergaard N, Hein M, Hyttel L, Helmig RB, Schonheyder HC, Uldbjerg N, Madsen H. Antibacterial properties of human amnion and chorion in vitro. Eur J Obst Gyn & Reprod Bio 2001; 94: 224-229. 8. Parolini O, et al. Human term placenta as a therapeutic agent: from the first clinical applications to future perspectives. In: Berven E, editor. Human placenta: structure and development. Hauppauge, New York: Nova Science Publishers, 2012: 1-48.

AMNIOEXCEL® and AMNIOMATRIX® are registered trademarks of BioD, LLC.